LHC Group Inc. (NASDAQ:LHCG) insider Joshua L. Proffitt sold 2,098 shares of the company’s stock in a transaction that occurred on Monday, November 7th. The stock was sold at an average price of $41.80, for a total value of $87,696.40. Following the completion of the sale, the insider now owns 64,717 shares of the company’s stock, valued at $2,705,170.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

LHC Group Inc. (NASDAQ:LHCG) opened at 41.95 on Thursday. The firm has a 50 day moving average price of $37.04 and a 200 day moving average price of $40.05. LHC Group Inc. has a 12-month low of $32.04 and a 12-month high of $49.34. The company has a market cap of $762.48 million, a PE ratio of 21.40 and a beta of 0.98.

LHC Group (NASDAQ:LHCG) last posted its quarterly earnings data on Wednesday, November 2nd. The company reported $0.54 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.50 by $0.04. The company earned $230 million during the quarter, compared to analyst estimates of $224.60 million. LHC Group had a net margin of 3.84% and a return on equity of 9.59%. The company’s revenue was up 13.1% on a year-over-year basis. During the same quarter last year, the business posted $0.50 earnings per share. On average, analysts anticipate that LHC Group Inc. will post $2.05 earnings per share for the current fiscal year.

Insider Buying and Selling by Quarter for LHC Group (NASDAQ:LHCG)

A number of equities research analysts have weighed in on LHCG shares. Oppenheimer Holdings Inc. restated an “outperform” rating and issued a $46.00 target price (down from $50.00) on shares of LHC Group in a research report on Tuesday, September 13th. Zacks Investment Research upgraded LHC Group from a “sell” rating to a “hold” rating in a research report on Wednesday, October 5th. Four analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average price target of $47.71.

Several hedge funds have recently bought and sold shares of the company. FMR LLC raised its stake in LHC Group by 3.3% in the second quarter. FMR LLC now owns 1,620,050 shares of the company’s stock valued at $70,116,000 after buying an additional 51,152 shares during the last quarter. Vanguard Group Inc. raised its stake in LHC Group by 4.1% in the second quarter. Vanguard Group Inc. now owns 1,445,895 shares of the company’s stock valued at $62,578,000 after buying an additional 57,246 shares during the last quarter. BlackRock Fund Advisors raised its stake in LHC Group by 15.6% in the third quarter. BlackRock Fund Advisors now owns 1,133,153 shares of the company’s stock valued at $41,791,000 after buying an additional 152,897 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in LHC Group by 2.8% in the second quarter. Dimensional Fund Advisors LP now owns 1,117,742 shares of the company’s stock valued at $48,375,000 after buying an additional 30,053 shares during the last quarter. Finally, Ameriprise Financial Inc. raised its stake in LHC Group by 0.7% in the third quarter. Ameriprise Financial Inc. now owns 520,513 shares of the company’s stock valued at $19,195,000 after buying an additional 3,596 shares during the last quarter. 79.25% of the stock is owned by institutional investors.

About LHC Group

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

5 Day Chart for NASDAQ:LHCG

Receive News & Stock Ratings for LHC Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group Inc. and related stocks with our FREE daily email newsletter.